Reclast Approved For Once Yearly Treatment Of Postmenopausal Osteoporosis
Zoledronic acid is the only osteoporosis therapy proven to reduce fractures across all key sites, Novartis claims.
Zoledronic acid is the only osteoporosis therapy proven to reduce fractures across all key sites, Novartis claims.